Paisley Capital discloses 6.7% stake in Conexeu
Paisley Capital Holdings Corp reported a significant ownership position in Conexeu Sciences Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Paisley Capital Holdings Corp reported a significant ownership position in Conexeu Sciences Inc. common stock. As of 06/30/2026, Paisley Capital beneficially owned 1,800,000 shares of Conexeu Sciences Inc. common stock, representing 6.7% of the class.
Paisley Capital, organized in the British Virgin Islands with a principal office in Baar, Switzerland, reported sole voting power and sole dispositive power over all 1,800,000 shares, with no shared voting or dispositive power. The certification section is marked as not applicable, and the filing is signed by Director Jacqueline Elsener on 07/16/2026.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake does Paisley Capital hold in Conexeu Sciences Inc. (CNXU)?
What dispositive power does Paisley Capital report over CNXU stock?
When was Paisley Capital’s CNXU ownership information dated and signed?
What class of Conexeu Sciences Inc. securities is reported in this Schedule 13G for CNXU?
AI-generated analysis. How Rhea-AI works. Not financial advice.